Dose not apply.
Conditions
Interventions
Intervention 1: Intervention group: 10 male smokers who did endurance training for 4 weeks (running, 3 days a week with an intensity above 50% of maximum heart rate) and took vitamin D supplement (100
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
24 Years to 38 Years
Inclusion criteria
Inclusion criteria: Have at least one year of smoking history Being male Healthy
Exclusion criteria
Exclusion criteria: Having a history of diabetes Having a history of cardiovascular disease Having food allergies Having a history of respiratory disease Use a sports supplement before or during the study Use the drug before or during the study Use of inflammatory agents before or during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum levels of interleukin 6 (IL-6) in male smokers. Timepoint: Blood sampling one day before the intervention and 24 hours after the intervention (2 stages). Method of measurement: Interleukin6 Kit.;Serum Tumor necrosis factor alpha (TNF-a) levels in male smokers. Timepoint: Blood sampling one day before the intervention and 24 hours after the intervention (2 stages). Method of measurement: TNF-a kit.;Serum levels of Clara cell protein (CC16) in male smokers. Timepoint: Blood sampling one day before the intervention and 24 hours after the intervention (2 stages). Method of measurement: CC16 kit.;Serum levels of surfactant protein-D (SP-D) in male smokers. Timepoint: Blood sampling one day before the intervention and 24 hours after the intervention (2 stages). Method of measurement: SP-D kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHadi pourmanaf
Tabriz University of Medical Sciences
Outcome results
None listed